by Orfenix | Oct 17, 2024
Barbara van den Aarsen Barbara has studied Biochemistry and obtained her Master’s degree at Leiden University. Barbara started her career in a niche CRO focusing on large cardiovascular clinical trials, where she held several roles, including CRA, CRM, and...
by Orfenix | Oct 17, 2024
Ivo de Nooijer Ivo has a biopharmaceutical sciences, Dutch law, and medical history degree. He is completing his PhD thesis, which investigates negotiations in early-stage licensing in the Netherlands’ life sciences and health sector. Ivo has worked in an...
by Orfenix | Oct 17, 2024
Vincent van der Wel Vincent holds degrees in Medicine, Business Studies, and Health Economics. This mix gives Vincent a good understanding of the clinical impact of treatments on clinicians and patients and the economic impact of drug development on payers,...
by Orfenix | Oct 17, 2024
Hellen Houlleberghs Hellen has an international academic background with a BSc in Medical Biochemistry from King’s College, University of London, an MSc in Biomedical Sciences and Management from the University of Leiden, and a PhD in oncology from the...
